NCT04704544View on ClinicalTrials.gov

Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis (EVOLVE)

NAActive, not recruitingINTERVENTIONAL
Enrollment

652

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

November 30, 2023

Study Completion Date

December 31, 2025

Conditions
Rheumatic Diseases
Interventions
OTHER

Tele-rheumatology

Participants will receive virtual visits via video conferencing and/or phone.

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

collaborator

Tulane University

OTHER

collaborator

Rheumatology Research Foundation

OTHER

lead

University of Alabama at Birmingham

OTHER